Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients—a randomized clinical trial
Christopher Adlbrecht, Jordi Rello(Centre Hospitalier Universitaire de Montpellier), Nina Wressnigg(Valneva (Austria)), Zsolt Molnár(Semmelweis University), Niranjan Kanesa-thasan(GlaxoSmithKline (United States)), Jacques Créteur, Andreas Meier‐Hellmann(Helios Kliniken), Mária Héjja(Országos Korányi Tbc és Pulmonológiai Intézet), Pieter Depuydt(Ghent University Hospital), Bernhard Schaaf(Klinikum Dortmund), Susanne Eder-Lingelbach(Valneva (Austria)), Thomas Staudinger(Northwestern University), Margot Vander Laenen(Ziekenhuis Oost-Limburg), Anton Klingler, Vladimír Šrámek, István Várkonyi(University of Debrecen), José A. Lorente(Universidad de Granada), Herbert Spapen(Universitair Ziekenhuis Brussel), Raphael Wurm(Medical University of Vienna), Katrin Dubischar(Valneva (Austria)), Hauke Schneider(University Hospital Augsburg), Philipp Eller(Federation of American Societies for Experimental Biology), Christian Zauner(Medical University of Vienna)
Cited by 83
Related Papers
Microvascular Blood Flow Is Altered in Patients with Sepsis
|American Journal of Respiratory and Critical Care Medicine|2002|1.5k
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
|CHEST Journal|2002|1.3k
Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock*
|Critical Care Medicine|2004|1.3k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k